Birdwatch Note
2021-11-13 20:06:02 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Regeneron, one of the few FDA emergency-authorized treatment drugs, was in short supply since its authorized used started in November 2020. There was not enough production to keep up with the COVID-19 hospitalization demand. https://www.reuters.com/article/us-health-coronavirus-regeneron-pharms-f/u-s-fda-grants-emergency-use-authorization-to-regeneron-covid-19-antibody-given-to-trump-idUSKBN28201L https://www.forbes.com/sites/jemimamcevoy/2021/09/10/nation-short-on-supply-of-key-covid-treatment-desperate-states-told-to-reduce-requests/?sh=7476ed026737
Written by 9795BF8962792425EFA8D2F4F92685B4
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1459608698586808323
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1459613545432289286
- noteId - 1459613545432289286
- participantId - 9795BF8962792425EFA8D2F4F92685B4
- noteAuthorParticipantId -
- createdAtMillis - 1636833962194
- tweetId - 1459608698586808323
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable - BELIEVABLE_BY_MANY
- harmful - CONSIDERABLE_HARM
- validationDifficulty - EASY
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Regeneron, one of the few FDA emergency-authorized treatment drugs, was in short supply since its authorized used started in November 2020. There was not enough production to keep up with the COVID-19 hospitalization demand. https://www.reuters.com/article/us-health-coronavirus-regeneron-pharms-f/u-s-fda-grants-emergency-use-authorization-to-regeneron-covid-19-antibody-given-to-trump-idUSKBN28201L https://www.forbes.com/sites/jemimamcevoy/2021/09/10/nation-short-on-supply-of-key-covid-treatment-desperate-states-told-to-reduce-requests/?sh=7476ed026737
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2021-11-13 20:06:02 UTC (1636833962194) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
47AD3BD4ED0E64C9EA74DB3A322FA6AA5E5F8D84E57A6E405CC624F53C571EC8 | |||
| 2021-11-13 20:06:02 UTC (1636833962194) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
9795BF8962792425EFA8D2F4F92685B4 |
Note Ratings
| rated at | rated by | |
| 2021-11-13 15:57:05 -0600 | 768C4C4EA7E7720283DD0F9889D728C4E17B575949BC8CFFC54ECE5EF81A8897 | Rating Details |
| 2021-11-13 19:48:26 -0600 | 887C0D03249F7754179A5366F67D3538C9345343867496F825FF4B4B9F260864 | Rating Details |
| 2021-11-14 07:33:46 -0600 | 99C9E6DE2BA16D23C320C1879BDDEE7DEA7686BE2B3B0C6B5AC5DD524EDA5D44 | Rating Details |
| 2021-11-13 14:10:45 -0600 | B37196BC9DCA4AFD8811CAF784DFCF11C78F3E5EE20D94FCDF4C8587F4F2DB9C | Rating Details |
| 2021-11-13 19:48:26 -0600 | Rating Details | |
| 2021-11-13 14:10:45 -0600 | Rating Details | |
| 2021-11-13 15:57:05 -0600 | Rating Details | |
| 2021-11-14 07:33:46 -0600 | Rating Details |